---
title: A seven percent solution
description: GLP-1s were a darned popular thing to prescribe ... but is that leveling off?
---

[APC News Feed | Stay Updated on Pharmacy Compounding ](https://a4pc.org/news)

# [A seven percent solution](https://a4pc.org/news/a-seven-percent-solution)

 Written by [Andrew](https://a4pc.org/news/author/andrew) | Jan 23, 2026

According to [the latest data from Truveta Research](https://www.truveta.com/blog/research/glp-1-ra-prescription-trends-december-2025?_hsenc=p2ANqtz--NbtklxWrTIHkTXH9mEXXil15Htz7olwauJZNROPPTx71S7LmOcOkzNWhwAK7nRU818rda), “As of December 2025, GLP-1 RA prescriptions account for more than 7% of all prescriptions”; tirzepatide leads the pack. Side note: While *overall* GLP-1 prescription rates rose slightly from September through December 2025, *new* prescriptions declined a bit, possibly because of the holidays. 

 

[View full post](https://a4pc.org/news/a-seven-percent-solution)

```json
{
  "@context" : "http://schema.org",
  "@type" : "BlogPosting",
  "author" : {
    "@type" : "Person",
    "name" : "Andrew"
  },
  "dateModified" : "2026-01-23T15:25:03.765Z",
  "datePublished" : "2026-01-23T15:25:03Z",
  "headline" : "A seven percent solution",
  "image" : {
    "@type" : "ImageObject",
    "height" : 458,
    "url" : "https://9189666.fs1.hubspotusercontent-na1.net/hubfs/9189666/image-png-3.png",
    "width" : 898
  },
  "mainEntityOfPage" : "https://a4pc.org/news/a-seven-percent-solution",
  "publisher" : {
    "@type" : "Organization",
    "logo" : {
      "@type" : "ImageObject",
      "height" : 60,
      "url" : "/hs/hsstatic/content_shared_assets/static-1.4092/img/default-amp-logo.png",
      "width" : 60
    },
    "name" : "APC News"
  }
}
```